RBC Capital Downgrades Celgene (CELG) to Sector Perform
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Rating Summary:
7 Buy, 27 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
7 Buy, 27 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
RBC Capital downgraded Celgene (NASDAQ: CELG) from Outperform to Sector Perform with a price target of $72.00 (from $74.00).
For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.
Shares of Celgene closed at $66.16 yesterday.
For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.
Shares of Celgene closed at $66.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Coloplast A/S (COLOB:DC) (CLPBY) PT Raised to DKK455 at Bernstein SocGen Group
- LVMH (MC:FP) (LVMUY) PT Lowered to EUR510 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
